Díaz Pérez de Madrid J, Muñoz Torres M, García de Vinuesa M J, Miján J L, Escobar Jiménez F, Zuluaga A
Arch Esp Urol. 1989 Mar;42(2):129-31.
A study was undertaken in 46 subjects; 21 patients diagnosed as having HRL and 25 volunteers patients. Biochemical and hormonal analyses were performed in the study population, including determination of Ca, P, Mg, Cr in blood and urine, phosphate tubular resorption (PTR), maximum tubular phosphate resorption (MTPR), fasting calcium secretion (FCS), alkaline phosphatase (AP), hydroxyprolinuria (HPR), osteocalcin (BGP), parathormone (PTH), cAMP, and 1-25(OH)2D. The stone formers showed lower calcemia values (p less than or equal to 0.005d), higher phosphaturia, and magnesiuria (p less than or equal to 0.0005), higher FCS (P less than or equal to 0.005) and higher values for PTH (p less than or equal to 0.01) and cAMP (p less than or equal to 0.0025). No significant differences were observed for the other parameters evaluated. Classification of the patient group into 2 subgroups (renal SbR and absorptive SbA) according to FCS values greater or lower that 0.16 mg/dl, the SbR patient group revealed a higher PTH and 1-25(OH)2D values (p less than or equal to 0.05). There appears to be no increase of bone resorption since AP, HPR, and BGP values in our patients fell within normal ranges. The 1-25(OH)2D levels were also normal and, with respect to the control group, were only elevated for the SbR patient group, whose PTH levels were also observed to be elevated. These increments appear to be related and may result in intermediate forms between renal and absorptive hypercalciuria.
对46名受试者进行了一项研究,其中21名被诊断为高钙尿症患者,25名志愿者。对研究人群进行了生化和激素分析,包括测定血液和尿液中的钙、磷、镁、铬、肾小管磷重吸收(PTR)、最大肾小管磷重吸收(MTPR)、空腹钙分泌(FCS)、碱性磷酸酶(AP)、羟脯氨酸尿(HPR)、骨钙素(BGP)、甲状旁腺激素(PTH)、环磷酸腺苷(cAMP)和1,25 - 二羟维生素D[1,25(OH)₂D]。结石形成者的血钙值较低(p≤0.005),尿磷和尿镁较高(p≤0.0005),FCS较高(P≤0.005),PTH和cAMP值较高(p≤0.01和p≤0.0025)。在所评估的其他参数方面未观察到显著差异。根据FCS值高于或低于0.16mg/dl将患者组分为2个亚组(肾性吸收型SbR和吸收性SbA),SbR患者组的PTH和1,25(OH)₂D值较高(p≤0.